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Sustained expression of CagA, the type IV secretion
effector of Helicobacter pylori, is closely associated
with the development of gastric cancer. However,
we observed that after translocation, CagA is
degraded by autophagy and therefore short lived.
Autophagy and CagA degradation are induced by
the H. pylori vacuolating cytotoxin, VacA, which
acted via decreasing intracellular glutathione (GSH)
levels, causing reactive oxygen species (ROS) accu-
mulation and Akt activation. Investigating this
further, we found that CagA specifically accumulated
in gastric cells expressing CD44, a cell-surface
marker associated with cancer stem cells. The auto-
phagic pathway in CD44-positive gastric cancer
stem-like cells is suppressed because of their
resistance to ROS, which is supported by increased
intracellular GSH levels. These findings provide a
molecular link between H. pylori and gastric carcino-
genesis through the specific accumulation of CagA
in gastric cancer stem-like cells.
INTRODUCTION
A possible link has been demonstrated between Helicobacter
pylori infection and development of gastric cancer by epidemio-
logical (Uemura et al., 2001) and animal studies (Suzuki et al.,
2009). Although long-term H. pylori infections of the gastric
mucosa might cause gastric cancer from severe inflammation,
no direct molecular link was demonstrated until Hatakeyama
reported that the transfer of H. pylori-derived CagA to epithelial
cells through a bacterial type IV secretion system promoted
an early event of gastric carcinogenesis (Hatakeyama, 2004).
Ohnishi et al. (2008) also demonstrated that systemic expression
of CagA in cagA-transgenic mice induced gastrointestinal malig-
nancies, indicating the oncogenic potential of bacterial CagA in
mammals. However, it was also reported that CagA, after trans-
location to gastric epithelial cells, does not persist for a long
period (Ishikawa et al., 2009).764 Cell Host & Microbe 12, 764–777, December 13, 2012 ª2012 ElsRecently, it has been reported that autophagy—a system for
bulk protein degradation and the elimination of invaded patho-
gens (Deretic and Levine, 2009)—is induced in H. pylori-infected
cells (Raju et al., 2012; Terebiznik et al., 2009). In the present
study, we observed that intracellular CagA was degraded by
autophagy induced by the accumulation of reactive oxygen
species (ROS), suggesting that CagA may not promote carcino-
genesis. Even if CagA escapes the autophagy system, intracel-
lular CagA could never be transferred to daughter cells and
would be lost after cell division. If translocated CagA does
indeed trigger gastric carcinogenesis, it should be transferred
to slow-cycling master-regulator cells and escape from auto-
phagic degradation.
CD44 is a cell-surface marker associated with cancer stem
cells in various tumors (Dalerba et al., 2007). Gastric cancer
stem-like cells expressing the variant isoform of CD44
(CD44v9) suppress ROS accumulation by control of intracellular
glutathione (GSH) levels by stabilizing xCT, a cystine transporter
(Ishimoto et al., 2011). In the present report, we used CD44v9-
expressing gastric cancer stem-like cells to study the ability of
intracellular CagA to escape from autophagy and show a direct
molecular link between H. pylori-derived CagA and gastric
cancer stem-like cells.
RESULTS
CagA Is Degraded by Autophagy
To investigate the stability of intracellular CagA, we constructed
an in vitro H. pylori infection model using a gastric cancer cell
line (AGS). After 5 hr of H. pylori ATCC700392 infection, the
AGS cells were incubated with kanamycin to kill extracellular
bacteria. In AGS cells after H. pylori eradication, the levels of
intracellular CagA and tyrosine-phosphorylated CagA (p-CagA)
decreased in a time-dependent manner (Figure 1A). Therefore,
intracellular CagA did not persist for a prolonged period in
gastric epithelial cells and was soon degraded by host cell
defenses.
To examine the mechanism of CagA degradation in host
epithelial cells, we used proteasome inhibitors (MG132 and lac-
tacystin [Lact]) and autophagy inhibitors (3-methyladenine [3MA]
and wortmannin [Wort]). At 24 hr after H. pylori ATCC700392
eradication, while intracellular CagA and p-CagA levels wereevier Inc.
Figure 1. Autophagy Induction Associated with Intracellular CagA Stability
(A) AGS cells infected with H. pylori ATCC700392 for 5 hr were incubated at indicated times in a medium containing antibiotic to kill extracellular bacteria.
Intracellular CagA and phosphorylated CagA (p-CagA) levels were quantified. Data represent the mean of three independent assays.
(B) AGS cells infected with H. pylori for 5 hr were incubated in a medium containing antibiotic with or without a proteasome inhibitor (10 mM MG132 or 20 mM
lactacystin [Lact]) or autophagy inhibitor (5 mM 3-methyladenine [3MA] or 50 nM wortmannin [Wort]) for 24 hr. Intracellular CagA and p-CagA levels were
quantified. Data represent the mean ± SD of three independent assays; *p < 0.05, **p < 0.01.
(C) AGS cells infected with H. pylori ATCC700392 for 5 hr were incubated in a medium containing antibiotic for the indicated times, and intracellular CagA and
LC3-I to LC3-II conversion were examined.
(D) After transfection of AGS cells with the EGFP-LC3B plasmid, cells infected with H. pylori for 5 hr were incubated with a medium containing antibiotic for 24 hr
with or without an autophagy inhibitor (10 mM MG132 or 20 mM Lact), and intracellular CagA was stained. EGFP-LC3B plasmid alone indicates the absence of
H. pylori infection. Scale bar = 25 mm.
(E) AGS cells infectedwithH. pyloriATCC700392 for 5 hr were incubated with amedium containing antibiotic for 24 hr, and LysoTracker RedDND-99 staining was
performed. Scale bar = 50 mm.
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Lact), they were significantly increased by exposure of the cells
to autophagy inhibitors (5 mM 3MA or 50 nMWort), as compared
with cells not exposed to these inhibitors (None) (Figure 1B).
These results indicated that autophagy contributed to CagA
degradation in host epithelial cells.Cell Host &We then examined whether autophagy was activated within
AGS cells after H. pylori ATCC700392 eradication. A hallmark
of autophagy is the carboxyl terminus modification of microtu-
bule-associated protein light chain 3 (LC3), which becomes
linked to phosphatidylethanolamine and associates with the
autophagosomal membrane. LC3-I to LC3-II conversion wasMicrobe 12, 764–777, December 13, 2012 ª2012 Elsevier Inc. 765
Figure 2. Degradation of Intracellular CagA
by the Induction of Autophagy
(A) CagA expression in WT-A10 cells was induced
by removal of Dox for 24 hr (CagA-expressing WT-
A10 cells). CagA-expressing WT-A10 cells were
stimulated with rapamycin for 24 hr, and intracel-
lular CagA and LC3-I to LC3-II conversion were
examined. Data represent the mean ± SD of three
independent assays; *p < 0.05.
(B) CagA-expressing WT-A10 cells stimulated
with 100 nM rapamycin for 24 hr were reacted
with a 15 nm immunogold-labeled antibody; im-
munogold-labeled CagA was detected by electron
microscopy. Arrows indicate immunogold-labeled
CagA. Label is autophagolysosomal components.
Scale bar = 200 nm.
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(Figure 1C). In addition, 24 hr after eradication, EGFP-LC3B-
positive puncta were clearly detected within the cytoplasm of
AGS cells transfected with the EGFP-LC3B plasmid, unlike
AGS cells exposed to autophagy inhibitors (5 mM 3MA, 50 nM
Wort) (Figure 1D), suggesting that LC3 is activated and localized
to autophagosomes. LysoTracker Red stains late autophagic
vacuoles (autolysosomes), but not early autophagosomes.
LysoTracker Red staining was clearly detected within AGS
cells at 24 hr after H. pylori eradication, consistent with the
formation of autolysosomes (Figure 1E). These results demon-
strate that autophagy was activated in AGS cells at 15 and
24 hr after eradication.
To evaluate whether autophagy was specifically associated
with degradation of intracellular CagA, CagA-expressing WT-
A10 cells—in which CagA expression was induced through the
pTet-off-cagA expression vector by the absence of doxycycline
(Dox) for 24 hr—was used.When these cells were incubated with
rapamycin, which promotes autophagy by inhibiting mammalian
target of rapamycin (mTOR), intracellular CagA decreased in
a dose-dependent manner, and LC3-I to LC3-II conversion
was clearly detected (Figure 2A). In addition, electron immuno-
cytochemical examination following immunogold labeling for
CagA in CagA-expressing, rapamycin-stimulated WT-A10 cells
revealed the presence of labeled CagA in autophagic vesicles
(Figure 2B). From these results, we conclude that intracellular
CagA is degraded by autophagy.
CagA Degradation via Autophagy Is Activated
by m1VacA
Although autophagy was activated in AGS cells after H. pylori
eradication (Figures 1C–1E), no LC3-I to LC3-II conversion was
detected in CagA-expressing WT-A10 cells without rapamycin
(Figure 2A; rapamycin [0 nM] lane). These results indicate that
the induction of autophagy was independent of intracellular
CagA, but was dependent on H. pylori infection. According to
Terebiznik et al. (2009), autophagy was induced by VacA in
H. pylori-infected AGS cells; therefore, we tested whether VacA
participated in induction of autophagy associated with CagA
degradation. In CagA-expressing WT-A10 cells exposed to
culture supernatant from H. pylori ATCC700392 (s1m1VacA),
intracellular CagA levels were significantly decreased in the766 Cell Host & Microbe 12, 764–777, December 13, 2012 ª2012 Elsculture supernatant in a dose-dependent manner with LC3-I to
LC3-II conversion (Figure 3A). In addition, in AGS cells at 24 hr
after H. pylori ATCC700392 (s1m1VacA) eradication, intracellular
CagA levels were significantly decreased, as compared to 15 hr
after eradication; conversionof LC3-I toLC3-IIwasclearlyevident
(Figure 3B). Conversely, inWT-A10 cells exposed toH. pylori F57
(VacA-negative), ot210 (s1m2VacA), or SS1 (s2m2VacA) culture
supernatant, there was no decrease in intracellular CagA levels,
and no LC3-I to LC3-II conversion was detected (Figure S1A).
Moreover, inAGScells at 24hr afterH.pyloriF57 (VacA-negative),
ot210 (s1m2VacA), or SS1 (s2m2VacA) eradication, there was no
decrease in intracellular CagA, and no LC3-I to LC3-II conversion
was detected (Figure S1B). To investigate the function of CagA
from each strain, we examined the tyrosine phosphorylation level
of eachCagA protein. All the CagA proteinswere phosphorylated
(Figure S1C), suggesting that those CagA species behaved simi-
larly in delivered host cells.
In CagA-expressing WT-A10 cells incubated with m1VacA for
24 hr, a significant m1VacA-dependent decrease in intracellular
CagA levels was observed along with LC3-I to LC3-II conversion
(Figure 3C). Autophagy inhibitors (5 mM 3MA or 50 nM Wort)
repressed the LC3-I to LC3-II conversion induced by m1VacA
and significantly increased intracellular CagA levels (Figure 3D).
In CagA-expressingWT-A10 cells incubated withm2VacA, intra-
cellular CagA was not degraded and LC3-I to LC3-II conversion
was not observed (Figure S1D). In addition, at 24 hr afterH. pylori
F57 (VacA-negative) eradication, there was a significant increase
in CagA, as compared with cells infected with H. pylori
ATCC700392 (s1m1VacA) (Figure S1E). The increase of intracel-
lular CagA produced by H. pylori F57 (VacA-negative) was
reduced by the addition of 60 nM m1VacA, in contrast to the
addition of 60 nM m2VacA (Figure S1E). To evaluate the biolog-
ical activity of VacA, we examined the vacuolation activity of
m1VacA and m2VacA. Both proteins induced vacuolation in
CagA-expressing WT-A10 cells in a dose-dependent manner,
although m1VacA induced stronger vacuolation activity than
m2VacA (Figure S1F). Our observations demonstrate that the
autophagy responsible for CagA degradation is induced by
m1VacA in gastric epithelial cells, independent of vacuolating
cytotoxicity.
We recently found that low-density lipoprotein receptor-
related protein-1 (LRP1) was one of the VacA receptors thatevier Inc.
Figure 3. Autophagy, Causing CagA Degradation, Is Induced by m1VacA
(A) CagA-expressing WT-A10 cells were stimulated with H. pylori ATCC700392 (s1m1VacA) culture supernatant, and intracellular CagA and LC3-I to LC3-II
conversion were examined. Data represent the mean ± SD of three independent assays; *p < 0.05.
(B) AGS cells infected with H. pylori (s1m1VacA) for 5 hr were incubated in a medium containing antibiotic for 15 and 24 hr, and intracellular CagA and LC3-I to
LC3-II conversion were examined. Data represent the mean ± SD of three independent assays; **p < 0.01.
(C) CagA-expressing WT-A10 cells were incubated with m1VacA for 24 hr, and intracellular CagA and LC3-I to LC3-II conversion were examined. Data represent
the mean ± SD of three independent assays; **p < 0.01.
(D) CagA-expressing WT-A10 cells, stimulated by m1VacA, were incubated with an autophagy inhibitor (5 mM 3MA or 50 nM Wort) for 24 hr, and intracellular
CagA and LC3-I to LC3-II conversion were examined. Data represent the mean ± SD of three independent assays; *p < 0.05, **p < 0.01. See also Figure S1.
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examine the relevance of LRP1 for the induction of autophagy-
mediated CagA degradation, we constructed specific LRP1-
knockdown AGS cells using small interfering RNAs (siRNAs)
(Figure S1G). The LRP1 knockdown repressed the LC3-I to
LC3-II conversion, resulting in the inhibition of CagA degradation
(Figure S1H). This result indicates that LRP1 is required for the
induction of autophagy-mediated CagA degradation in response
to m1VacA. Next, to compare the binding ability of m1VacA and
m2VacA to LRP1, we performed an immunoprecipitation assay
with anti-LRP1. An 87 kDa fragment of VacA was detected by
western blotting with an anti-VacA antibody in the anti-LRP1
immunoprecipitates from AGS cells infected with H. pylori
ATCC700392 (s1m1VacA) (Figure S1I). In contrast, VacA was
not detected in the anti-LRP1 immunoprecipitates from AGS
cells infected with H. pylori ot210 (s1m2VacA) (Figure S1I). This
result demonstrates thatm1VacA, but notm2VacA, has a binding
potential to LRP1.
p53 Downregulation via Increased MDM2-
Phosphorylation Induces Autophagy, Causing
CagA Degradation
p53 inactivation by chemical inhibition or knockdown induces
autophagy via the inhibition of mTOR. To investigate the induc-Cell Host &tion of autophagy associated with CagA degradation, we
examined p53 expression in AGS cells after H. pylori infection.
In AGS cells at 15 and 24 hr after eradication of H. pylori
ATCC700392 (s1m1VacA), p53 expression was significantly
decreased and LC3-I to LC3-II conversion was clearly de-
tected (Figure 4A). We then examined the mechanisms of
p53 downregulation, focusing on posttranslational mecha-
nisms, since H. pylori-infected AGS cells have been reported
to show no change in p53 mRNA expression (Wei et al.,
2010). It is well known that p53 can be degraded by ubiquiti-
nation and proteasomal degradation pathways and that murine
double minute 2 (MDM2) is the main E3 ubiquitin ligase that
mediates p53 degradation. MDM2 expression was unaltered
in AGS cells after H. pylori ATCC700392 (s1m1VacA) in-
fection (Figure 4B). MDM2 is activated by phosphorylation at
Ser166 (pMDM2) (Zhou et al., 2001). At 15 and 24 hr after
the eradication of H. pylori ATCC700392 (s1m1VacA), pMDM2
levels were significantly increased (Figure 4B). Conversely,
in AGS cells after H. pylori F57 (VacA-negative), ot210
(s1m2VacA), or SS1 (s2m2VacA) infection, neither a decrease
in p53 expression nor an increase in pMDM2 was noted
(Figure S2).
We then examined the relationship between p53 down-
regulation and intracellular CagA stability. The specificMicrobe 12, 764–777, December 13, 2012 ª2012 Elsevier Inc. 767
Figure 4. Autophagy, Causing CagA Degra-
dation, Is Induced through MDM2-Mediated
p53 Degradation
(A) AGS cells infected withH. pylori (s1m1VacA) for
5 hr were incubated in a medium containing anti-
biotic for the indicated time, and p53 expression
and LC3-I to LC3-II conversion were examined.
Data represent the mean ± SD of three indepen-
dent assays; **p < 0.01, compared to AGS cells at
0 hr after H. pylori (s1m1VacA) eradication.
(B) AGS cells infected with H. pylori (s1m1VacA)
for 5 hr were incubated in a medium containing
antibiotic for the indicated times, and the levels of
MDM2 and phosphorylated-MDM2 (pMDM2)
were examined. Data represent the mean ± SD of
three independent assays; **p < 0.01, compared
to AGS cells at 0 hr after H. pylori (s1m1VacA)
eradication.
(C) After AGS cells were transfected with control
siRNA or p53 siRNA, cells infected with H. pylori
(s1m1VacA) for 5 hr were incubated in a medium
containing antibiotic for the indicated times, and
the levels of CagA, p53 expression, and LC3-I to
LC3-II conversion were examined. Data represent
the mean ± SD of three independent assays;
**p < 0.01, compared to AGS cells transfected
with control siRNA at each time point after
H. pylori (s1m1VacA) eradication.
(D) KATOIII cells were transfected with the pCMV-
Neo-Bam WT p53 plasmid (p53-WT) or without
(Cont). Each cell after H. pylori (s1m1VacA)
infection for 5 hr was incubated in a medium
containing antibiotic for the indicated times. CagA
levels and LC3-I to LC3-II conversion were
examined. Data represent the mean ± SD of three
independent assays; **p < 0.01; lipofect indicates
KATOIII cells treated with only Lipofectamine
2000.
(E) AGS cells infected with H. pylori (s1m1VacA)
for 5 hr were incubated in a medium containing
antibiotic for the indicated times with 10 mMnutlin-
3, and the levels of CagA, p53 expression, and
LC3-I to LC3-II conversion were examined. Data
represent the mean ± SD of three independent
assays; NS, not significant. See also Figure S2.
Cell Host & Microbe
CagA Accumulation in Gastric Cancer Stem Cellsp53-knockdown using small interfering RNAs (siRNAs) acceler-
ated LC3-I to LC3-II conversion, thereby enhancing CagA degra-
dation in AGS cells after H. pylori ATCC700392 (s1m1VacA)
infection (Figure 4C). Moreover, in KATOIII cells, which are
genetically deficient of p53 (p53/ KATOIII cells), LC3-I to
LC3-II conversion was clearly detected at 24 hr after the eradica-
tion of H. pylori ATCC700392 (s1m1VacA), and intracellular
CagA levels were significantly decreased, as compared with
p53/ KATOIII cells transfected with the WT p53 expression
plasmid (Figure 4D). In addition, we examined the effect of nut-768 Cell Host & Microbe 12, 764–777, December 13, 2012 ª2012 Elsevier Inc.lin-3—an inhibitor of MDM2-phosphory-
lation—on CagA stability. Treatment with
10 mM nutlin-3 repressed p53 downregu-
lation and LC3-I to LC3-II conversion (Fig-
ure 4E), resulting in the inhibition of CagA
degradation (Figure 4E). These results
show that p53 downregulation, throughthe acceleration of MDM2-phosphorylation by m1VacA, induces
autophagy, causing CagA degradation.
ROS Accumulation Is Necessary for the Induction
of Autophagy, Causing CagA Degradation
An accumulation of intracellular ROS induces autophagy,
and the generation of intracellular ROS is enhanced in gastric
epithelial cells during H. pylori infection (Ding et al., 2007). We
hypothesized that the enhanced generation of intracellular
ROS participates in induction of autophagy, causing CagA
Cell Host & Microbe
CagA Accumulation in Gastric Cancer Stem Cellsdegradation. AGS cells at 15 and 24 hr after the eradication of
infected H. pylori were analyzed using fluorescence microscopy
and flow cytometry after staining with CM-H2DCFDA, an
ROS-sensitive fluorescent probe. Hydrolyzed CM-H2DCFDA is
oxidized to dichlorofluorescein (DCF) by intracellular ROS
(Suzuki et al., 1994). DCF fluorescence was apparent in AGS
cells at 15 and 24 hr after the eradication of H. pylori
ATCC700392 (s1m1VacA), as compared with AGS cells without
H. pylori exposure (Figure 5A). The intensity of DCF fluorescence
in AGS cells at 15 and 24 hr after the eradication of H. pylori
ATCC700392 (s1m1VacA) was significantly increased, as
compared to AGS cells without H. pylori exposure (Figure 5B).
Conversely, in AGS cells after H. pylori F57 (VacA-negative),
ot210 (s1m2VacA), or SS1 (s2m2VacA) infection, no increase in
DCF fluorescence was observed (Figure S3A). These results
show that the accumulation of intracellular ROS was enhanced
during the induction of autophagy.
NADPH oxidase (NOX)-generated ROS is a key regulator of
autophagy (Huang et al., 2009), while mitochondrial-superoxide
(O2
) production is involved in the induction of autophagy
(Scherz-Shouval and Elazar, 2007). To identify the source of
enhanced ROS generation associated with the induction of auto-
phagy through p53 downregulation, we examined the effects of
an NOX inhibitor (acetovanillone), an MnSOD mimic compound
(MnTMPyP), and N-acetylcysteine (NAC). p53 downregulation
was not inhibited by 250 mM acetovanillone or 20 mMMnTMPyP;
therefore, LC3-I to LC3-II conversion was not repressed (Fig-
ure 5C). Conversely, p53 downregulation was inhibited by treat-
ment with 10 mM NAC, and LC3-I to LC3-II conversion was
repressed (Figure 5C). Moreover, intracellular CagA levels were
significantly increased by treatment of AGS cells with 10 mM
NAC at 24 hr after the eradication of H. pylori ATCC700392
(s1m1VacA) (Figure 5D). These results show that the accumula-
tion of intracellular ROS is necessary for induction of autophagy,
causing CagA degradation, independent of NOX- andmitochon-
dria-associated ROS generation.
Administration of NAC, a cysteine prodrug, replenishes intra-
cellular GSH levels; therefore, NAC has been used to treat
GSH deficiency (Atkuri et al., 2007). We hypothesized that the
accumulation of intracellular ROS during the induction of auto-
phagy was caused by decreased GSH levels. To prove this,
we examined the change of GSH levels in AGS cells after
H. pylori ATCC700392 (s1m1VacA) infection. Intracellular GSH
levels in AGS cells at 15 and 24 hr after the eradication of
H. pyloriATCC700392 (s1m1VacA) were significantly decreased,
as compared to AGS cells withoutH. pylori exposure (Figure 5E).
Moreover, intracellular GSH levels in AGS and CagA-expressing
WT-A10 cells were significantly decreased bym1VacA in a dose-
dependent manner (Figure 5F). In AGS cells at 15 and 24 hr after
the eradication of H. pylori ATCC700392 (s1m1VacA), intracel-
lular GSH was decreased, as compared to cells at 15 and
24 hr after eradication of H. pylori F57 (VacA-negative), ot210
(s1m2VacA), or SS1 (s2m2VacA) (Figure S3B). Moreover, intra-
cellular GSH levels in AGS and CagA-expressing WT-A10 cells
were not decreased by treatment with m2VacA (Figure S3C).
These results show that the accumulation of intracellular ROS
associated with the induction of autophagy was induced by
decreased GSH levels caused by m1VacA. Next, to provide
the relevance of LRP1 in the reduction of intracellular GSH levels,Cell Host &we measured intracellular GSH levels in specific LRP1-knock-
down AGS cells; they were significantly increased at 15 or
24 hr after the eradication of H. pylori ATCC700392 (s1m1VacA),
as compared with those in AGS cells transfected with control
siRNA (Figure S3D). These results demonstrate that the binding
of m1VacA to LRP1 is required for the reduction of intracellular
GSH levels.
Activation of the Akt Pathway Depends on the
Accumulation of ROS for Autophagy Induction
Phosphorylated Akt enhances the ubiquitination-promoting
function of MDM2 by phosphorylation, resulting in p53 downre-
gulation (Ogawara et al., 2002). In addition, exogenous and
endogenous ROS enhance Akt phosphorylation (Dong-
Yun et al., 2003). We hypothesized that the accumulation of
intracellular ROS by decreased GSH levels enhances Akt phos-
phorylation, leading to the induction of autophagy through p53
downregulation by the activation of MDM2. To investigate this
hypothesis, we examined Akt phosphorylation in AGS cells after
H. pylori ATCC700392 (s1m1VacA) infection. Although Akt
expression was unaltered, the levels of phosphorylated Akt at
Thr308 and Ser473 were significantly increased in AGS cells
after H. pylori ATCC700392 (s1m1VacA) infection (Figure 6A).
To examine whether Akt phosphorylation depends on the accu-
mulation of intracellular ROS, we examined the effect of NAC
on Akt phosphorylation. Treatment with 10 mM NAC inhibited
Akt phosphorylation at Ser473, but not at Thr308 (Figure 6A);
therefore, Akt phosphorylation at Ser473 was dependent on
accumulation of intracellular ROS after H. pylori ATCC700392
(s1m1VacA) infection. In addition, although Akt phosphorylation
at Thr308 was increased in AGS cells after H. pylori F57 (VacA-
negative), ot210 (s1m2VacA), or SS1 (s2m2VacA) infection, Akt
phosphorylation at Ser473 was not increased (Figure S4A).
Moreover, Akt phosphorylation at Thr308 and Ser473 was not
increased in CagA-expressing WT-A10 cells, suggesting that
Akt phosphorylation was independent of intracellular CagA
(Figure S4B).
To examine the relevance of Akt phosphorylation at Ser473 to
the induction of autophagy, causing CagA degradation, we
examined the effect of LY294002, an inhibitor of Akt phosphory-
lation, on the stability of intracellular CagA and autophagy induc-
tion. Ten micromolar LY294002 inhibited intracellular CagA
degradation, the increase in pMDM2, and p53 downregulation
(Figure 6B). As a result, LC3-I to LC3-II conversion in AGS cells
at 15 and 24 hr after the eradication of H. pylori ATCC700392
(s1m1VacA) was repressed by LY294002 with reduced accumu-
lation of LysoTracker Red (Figure 6C). These results suggest that
enhanced Akt phosphorylation at Ser473 induced MDM2 phos-
phorylation, leading to the induction of autophagy and causing
CagA degradation through p53 downregulation.
Accumulation of Translocated CagA in CD44v9-
Expressing Gastric Cancer Stem-like Cells
Intracellular CagA produced by m1VacA H. pylori, but not
m2VacA H. pylori, was degraded by autophagy. Although some
studies indicated thatm1VacAH. pylori infection was at a greater
risk of gastric cancer compared with m2VacA H. pylori infection
(Basso et al., 2008; Miehlke et al., 2000), others have indicated
that there is no correlation between virulence and the vacAMicrobe 12, 764–777, December 13, 2012 ª2012 Elsevier Inc. 769
Figure 5. Reduced Intracellular GSH Levels Trigger Autophagy, Causing CagA Degradation
(A) AGS cells at 24 hr after H. pylori (s1m1VacA) eradication were stained with CM-H2DCFDA and MitoTracker Red FM and examined by fluorescence
microscopy. Scale bar = 50 mm.
(B) Flow cytometry of AGS cells at 15 and 24 hr after H. pylori (s1m1VacA) eradication. H2DCF fluorescence intensity was determined by using analysis software.
Data represent the mean ± SD of three independent assays; **p < 0.01.
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CagA Accumulation in Gastric Cancer Stem Cellsgenotype (Marshall et al., 1999; Yamaoka et al., 1998). In fact, m1
andm2VacA strains are both observed in gastric cancer patients
(Wang et al., 1998). From these reports, we hypothesized that
there was a characteristic alteration in host cell associated with
the inhibitionof autophagy,which led to theaccumulationof intra-
cellular CagA. CD44v9-expressing gastric cancer cells are resis-
tant to ROS, supported by increased intracellular GSH synthesis
(Ishimoto et al., 2011). We hypothesized that accumulation of
intracellular CagA resulted from inhibiting autophagy induction
in CD44v9-expressing cells. To prove this hypothesis, we pre-
pared MKN28 mutant cells by transfection of CD44 standard
form (CD44s)- orCD44v9-expression vectors intoCD44-negative
MKN28 cells (Ishimotoet al., 2011). CD44sorCD44v9expression
inMKN28 cells was confirmed using flow cytometry (Figure S5A).
Intracellular GSH levels in MKN28 cells expressing CD44s were
significantly increased in comparison to MKN28 cells, whereas
GSH levels in MKN28 cells expressing CD44v9 were increased
in comparison to MKN28 cells expressing CD44s (Figure S5B).
These results were consistent with previous observations that
CD44v9 expression increases cellular GSH contents through
the promotion of xCT-mediated cystine uptake, and CD44s
expression increases cellular GSH levels through the mainte-
nance of pentose phosphate pathway (PPP) flux and consequent
NADPHproduction (Tamada et al., 2012). IntracellularGSH levels
in MKN28 cells expressing CD44v9 were not decreased at 15 or
24 hr after the eradication of H. pylori ATCC700392 (s1m1VacA),
in contrast to the reduction ofGSH levels inMKN28cells express-
ing CD44s (Figure 7A). Intracellular CagA levels were significantly
increased inMKN28 cells expressing CD44v9, as compared with
those in MKN28 cells expressing CD44s (Figure 7B). In addition,
the increaseof Akt andMDM2phosphorylation andp53degrada-
tion were not observed in MKN28 cells expressing CD44v9
(Figure 7B). As a result, LC3-I to LC3-II conversionwas repressed
(Figure 7B) and LysoTracker signals were markedly decreased in
MKN28 cells expressing CD44v9 (Figure 7C). These results
suggest that intracellular CagA accumulated in cells expressing
CD44v9 through the inhibition of autophagy. We then examined
the effect of sulfasalazine, a potent xCT inhibitor, on the stability
of intracellularCagA inMKN28cells expressingCD44v9. Intracel-
lular CagA levels were decreased by the application of sulfasala-
zine in a dose-dependent fashion (Figure 7D). Moreover, Akt and
MDM2 phosphorylation was significantly increased, and p53
downregulation was induced by treatment with sulfasalazine
(Figure 7D), resulting in a significant increase in the conversion
of LC3-I to LC3-II (Figure 7D).
To assess the effect of CD44v9-expression on the accumula-
tion of intracellular CagA in human gastric adenocarcinoma,
endoscopically resected early gastric cancer tissue from(C) AGS cells infected withH. pylori (s1m1VacA) for 5 hr were incubated in amediu
inhibitor), 20 mM MnTMPyP (MnSOD mimic), or 10 mM NAC. p53 expression a
independent assays; *p < 0.05, **p < 0.01, compared to AGS cells at 0 hr after e
(D) AGS cells infected withH. pylori (s1m1VacA) for 5 hr were incubated in amediu
inhibitor), 20 mMMnTMPyP (MnSOD mimic), or 10 mM NAC, and intracellular Ca
assays; **p < 0.01. None indicates without inhibitor.
(E) AGS cells infected with H. pylori (s1m1VacA) for 5 hr were incubated in a me
measured. Data represent the mean ± SD of three independent assays; **p < 0.0
(F) AGS cells or CagA-expressing WT-A10 cells were incubated with m1VacA for
SD of three independent assays; **p < 0.01. See also Figure S3.
Cell Host &four patients (case 1: 62-year-old female, well-differentiated
adenocarcinoma, H. pylori-positive; case 2: 68-year-old male,
well-differentiated adenocarcinoma, H. pylori-positive; case 3:
72-year-old male, well-differentiated adenocarcinoma,H. pylori-
positive; case 4: 78-year-old male, well-differentiated adenocar-
cinoma, H. pylori-positive), with written informed consent, was
used. Remarkable intracellular CagA staining was detected
with an anti-CagA antibody in the CD44v9-positive cells in
each gastric adenocarcinoma (Figure 7E). It was confirmed using
an anti-H. pylori antibody that these CagA-stained patterns were
different from H. pylori-specific staining (not CagA) (data not
shown), suggesting that only transported CagA, but not the
H. pylori itself, was detected in CD44v9-expressing gastric
cancer tissue. Endoscopically resected early gastric cancer
tissue from an H. pylori-negative patient (80-year-old female,
well-differentiated adenocarcinoma), with written informed
consent, was used as a CagA-negative control. In this specimen,
intracellular CagA staining was not detected in either CD44v9-
positive or CD44v9-negative cells (Figure S5C). In addition,
we detected the intracellular CagA-negative region in both
CD44v9-positive and CD44v9-negative cells in endoscopically
resected early gastric cancer tissue from a patient at 40 months
after H. pylori eradication (72-year-old male, well-differentiated
adenocarcinoma), with written informed consent (Figure S5D).
In addition to performing a general pathological assessment,
LC3B and CD44v9 were stained using fluorescent immuno-
histochemistry for a paraffin-embedded pathological tissue
specimen. In cells expressing CD44v9, there were fewer
LC3B-positive puncta than in CD44v9-negative cells, suggesting
that autophagy was repressed within the CD44v9-positive cells
(Figure 7F). These results indicate that the accumulation of intra-
cellular CagA with autophagy inhibition was confirmed in
CD44v9-expressing cancer stem-like cells of human gastric
adenocarcinoma.
DISCUSSION
The present study reveals that the accumulation of intracellular
CagA in CD44v9-expressing cancer stem-like cells is caused
by the repression of autophagy. The autophagic pathway asso-
ciated with CagA degradation is induced as follows: m1VacA-
induced GSH deficiency via binding to LRP1 and then enhances
Akt phosphorylation at Ser473. Activation of Akt inducesMDM2-
mediated p53 degradation through the ubiquitin-proteasome
system and then activates autophagy.
Figures S1I and S3D indicated that binding ofm1VacA to LRP1
was required for the reduction of intracellular GSH levels and the
induction of autophagy, causing CagA degradation. In contrast,mcontaining antibiotic for the indicated timeswith 250 mMacetovanillone (NOX
nd LC3-II formation were examined. Data represent the mean ± SD of three
radication (p53-expression, middle panel). None indicates without inhibitor.
m containing antibiotic for the indicated timeswith 250 mMacetovanillone (NOX
gA levels were examined. Data represent the mean ± SD of three independent
dium containing antibiotic for 15 and 24 hr, and intracellular GSH levels were
1.
24 hr, and intracellular GSH levels were measured. Data represent the mean ±
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Figure 6. Akt Phosphorylation in Response to Intracellular ROS Accumulation Contributes to Induction of Autophagy, Causing CagA
Degradation
(A) AGS cells infected with H. pylori for 5 hr were incubated in a medium containing antibiotic for the indicated times, with or without 10 mM NAC. Akt phos-
phorylation at Thr308 and Ser473 was examined. Data represent the mean ± SD of three independent assays; *p < 0.05, compared to AGS cells at 0 hr after
eradication (right panel).
(B) AGS cells infected with H. pylori for 5 hr were incubated in a medium containing antibiotic for the indicated time with 10 mM LY294002 (Akt-phosphorylation
inhibitor), and the levels of intracellular CagA, pMDM, and p53 were examined. Data represent the mean ± SD of three independent assays; NS, not significant.
(C) AGS cells infected with H. pylori for 5 hr were incubated in a medium containing antibiotic for the indicated times with 10 mM LY294002 (Akt-phosphorylation
inhibitor), and LC3-II formation was examined. Data represent the mean ± SD of three independent assays; *p < 0.05, **p < 0.01. AGS cells at 24 hr after
eradication with or without LY294002 were stained using LysoTracker Red DND-99 (right panel). Scale bar = 50 mm. See also Figure S4.
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CagA Accumulation in Gastric Cancer Stem Cellsthe binding to LRP1 of m2VacA was not detectable by immuno-
precipitation assay (Figure S1I). It has been reported that the
mid-region of VacA has an important role in the binding of
VacA to host cells (Cover and Blanke, 2005). Therefore, these
findings suggest that the reason m2VacA could not induce772 Cell Host & Microbe 12, 764–777, December 13, 2012 ª2012 Elsautophagy was the lack of binding ability to LRP1, unlike
m1VacA.
Our observations indicate that m1VacA reduces intracellular
CagA levels via the induction of autophagy (Figure 3). Intracel-
lular CagA deregulates SHP-2 and PAR1, which promote cellevier Inc.
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CagA Accumulation in Gastric Cancer Stem Cellsproliferation, thus causing loss of cell polarity (Saito et al., 2010).
Therefore, an excess of intracellular CagA leads to cell damage
that disturbs the attachment of bacteria to gastric epithelial cells.
Recently, it was suggested that VacA can downregulate CagA-
induced signal-transduction in gastric epithelial cells to some
extent, thus minimizing the degree of cellular damage (Yo-
koyama et al., 2005). Therefore, this CagA degradation response
to VacA is considered an important strategy for the long-term
colonization of the gastric mucosa by H. pylori.
H. pylori ATCC700392-derived CagA contains the EPIYA-ABC
motif, and CagA expressed in WT-A10 cells contains the EPIYA-
ABCCC motif derived from H. pylori NCTC11637. Our data
showed that both of these types of CagA were degraded by
autophagy induced by m1VacA (Figures 1, 2, and 3). These
results suggest that CagA degradation by autophagy is not
affected by differences in the EPIYA motif.
A number of studies demonstrated a link between CagA and
gastric cancer development (Blaser et al., 1995; Huang et al.,
2003). However, intracellular CagA was only detected in the
gastric mucosa of H. pylori-infected patients with atrophic
gastritis, and not in the gastric mucosa of patients with intestinal
metaplasia or cancer (Yamazaki et al., 2003). Therefore, CagA
was thought to play a causative role at a relatively early phase
of gastric carcinogenesis. Our findings indicate that intracellular
CagA is degraded by autophagy induced by the accumulation of
intracellular ROS. Thus, even if CagA is translocated into a host
cell, it does not persist for a long period. The accumulation of
intracellular CagA is restricted to cells in which autophagy is sup-
pressed. We demonstrated that intracellular CagA specifically
accumulates in CD44v9-expressing human gastric cancer cells
in which CagA degradation by autophagy has been suppressed
by their resistance to ROS (Figure 7E). Thus, we show a direct
molecular link between CagA and gastric cancer stem-like cells
and suggest that the role of CagA in gastric carcinogenesis is not
restricted to the early phase.
Chronic inflammation triggers the expression of CD44s (Ishi-
moto et al., 2010), suggesting that chronic severe inflammation
after long-term H. pylori colonization induces CD44 expression
in normal gastric epithelial cells. CD44-expressing cells have
increased intracellular GSH levels, as compared to CD44-nega-
tive cells, by maintaining PPP flux and the consequent produc-
tion of NADPH (Tamada et al., 2012) (Figure S5B), suggesting
that CD44-positive cells are slightly resistant to oxidative stress.
Conversely, CD44v9-expressing cells are more resistant to
oxidative stress, compared with CD44s-expressing cells, by
enhancing intracellular GSH levels through the promotion of
xCT-mediated cystine uptake (Ishimoto et al., 2011) (Figure S5B).
Thus, CagA specifically accumulates in CD44v9-expressing
cells by escaping from the autophagy induced by ROS (Figure 7).
Additionally, the mRNA expression of lgr5, one of the markers of
stem cells besides CD44, was not detectable in the CD44- or
CD44v9-expressing MKN28 cells (data not shown). Takaishi
et al. (2009) reported that the expression of other potential cell-
surface markers did not show any correlation with CD44-ex-
pressing gastric cancer stem cells. From these findings, we
conclude that the accumulation of intracellular CagA by inhibi-
tion of autophagy is a specific character of CD44v9-expressing
gastric cancer stem-like cells because of their resistance of
ROS, and it does not correlate with LGR5. A variety of CD44 iso-Cell Host &forms are generated by alternative splicing of the pre-mRNA.
CD44v9 is one of the CD44 isoforms and is expressed in gastric
cancer stem cells (Mayer et al., 1993). In addition, H. pylori infec-
tion induced CD44v9 expression, suggesting that the develop-
ment of cells that accumulate CagA can be caused by H. pylori
infection (Fan et al., 1996). CD44v9 expression, which is regu-
lated by epithelial splicing regulatory protein 1, plays a functional
role in carcinogenesis, differentiation, and metastasis (Yae et al.,
2012). In addition, CagA oncogenic signals were maintained in
CD44v9-expressing cancer stem-like cells in the present study.
xCT, stabilized byCD44v9, plays an important role inmaintain-
ing intracellular redox balance (Patel et al., 2004). Sulfasalazine,
a potent xCT inhibitor that has been used routinely for the treat-
ment of inflammatory bowel disease and rheumatoid arthritis,
suppresses metastasis of CD44v9-expressing lung cancer and
inhibits hepatocellular carcinoma cell growth (Yae et al., 2012).
In the present study, sulfasalazine also inhibited the accumula-
tion of intracellular CagA in CD44v9-expressing cells by sup-
pressing autophagy (Figure 7D), suggesting a prophylactic effect
for sulfasalazine against CagA-dependent gastric cancer devel-
opment, especially by targeting cancer stemness.
EXPERIMENTAL PROCEDURES
In Vitro H. pylori Infection Model
Cells were incubated with s1m1VacA H. pylori, VacA-negative H. pylori,
s1m2VacA H. pylori, and s2m2VacA H. pylori for 5 hr (multiplicity of infection
of 50), and the cells were incubated with RPMI1640 culture medium containing
400 mg/ml kanamycin to kill extracellular bacteria with or without each inhibitor
(MG132, Lact, 3MA,Wort, LY294002, nutlin-3, or sulfasalazine) or each antiox-
idant (acetovanillone, MnTMPyP, or NAC) for the indicated incubation period
(0, 3, 15, and 24 hr). The cells were then washed three times with PBS and
harvested.
Preparation of H. pylori Culture Supernatants
s1m1VacA, VacA-negative, s1m2VacA, and s2m2VacA H. pylori, normalized
to an OD600 of 0.3, were transferred to cell culture medium (RPMI1640medium
supplemented with 10% FBS) and cultured for a further 15 hr. The superna-
tants were collected by centrifugation, passed through 0.22 mm filter units to
remove any bacteria, and diluted with fresh medium.
Immunohistochemistry
Tissue was fixed in 4% paraformaldehyde, embedded in paraffin, and
sectioned at a thickness of 4 mm. The sections were depleted of paraffin and
then rehydrated in a graded series of ethanol solutions. For immunohisto-
chemistry, the sections were washed in Tris-buffered saline with Tween-20
(TBS-T) and subjected to antigen retrieval by heating for 10 min at 105C in
Target Retrieval Solution (pH 9.0) (Dako, Tokyo). Nonspecific binding was
blocked by Protein Block (Dako). The sections were incubated overnight at
4C with primary antibody (see Supplemental Experimental Procedures).
Immunoreactivity was detected using Alexa Fluor 568-conjugated goat
anti-mouse IgG (Invitrogen, Carlsbad, CA), Alexa Fluor 568-conjugated goat
anti-rabbit IgG (Invitrogen), and Alexa Fluor 488-conjugated goat anti-rat IgG
(Invitrogen). The samples were examined using an FV10i fluorescence micro-
scope (Olympus, Tokyo).
Electron Immunocytochemistry
CagA-expressing WT-A10 cells stimulated with 100 nM rapamycin for 24 hr
were fixed with 4% paraformaldehyde and 0.1% glutaraldehyde for 80 min.
The specimens were then dehydrated in a graded ethanol series and pro-
cessed with a postembedding immunocytochemical technique using reduced
osmium and acrylate resin. Immunogold labeling was performed by incubation
with an anti-CagA goat polyclonal antibody (bK-300, 1:1000, Santa Cruz
Biotechnology), followed by the addition of secondary antibodies conjugatedMicrobe 12, 764–777, December 13, 2012 ª2012 Elsevier Inc. 773
Figure 7. Accumulation of Intracellular CagA Is Detected in CD44v9-Expressing Gastric Cancer Stem-like Cells
(A) MKN28 cells were transfected with the pRC/CMV-CD44s or pRC/CMV-CD44v expression plasmid; cells infected with H. pylori (s1m1VacA) for 5 hr were
incubated in a medium containing antibiotic for 15 and 24 hr, and intracellular GSH levels were examined. Data represent the mean ± SD of three independent
assays; *p < 0.05, **p < 0.01; NS, not significant.
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CagA Accumulation in Gastric Cancer Stem Cellsto 15 nm gold particles. The sections were poststained with uranyl acetate and
modified Sato’s lead solution and visualized using a JEM-1200EX electron
microscope (JEOL, Tokyo).
Cell Vacuolation Assay
CagA expression in WT-A10 cells was induced by treatment with m1VacA or
m2VacA for 24 hr, and the extent of vacuolation was determined quantitatively
by measuring the uptake of neutral red.
Immunoprecipitation Assay
After s1m1VacA and s1m2VacAH. pylori infection for 5 hr, the cell lysates were
incubated overnight with anti-LRP1monoclonal antibody (Santa Cruz Biotech-
nology) at 4C. This was followed by the addition of EZview Red Protein A
Affinity Gel (Sigma) and overnight incubation. Proteins were detected using
antibodies against VacA (Yahiro et al., 1999).
Fluorescence Immunocytochemistry
To detect EGFP-LC3B signals, AGS cells transfected with the EGFP-LC3B
plasmid were infected with H. pylori for 5 hr. The cells were incubated with
RPMI1640 culture medium containing 400 mg/ml kanamycin—with or without
an autophagy inhibitor (3MA andWort)—for 24 hr, fixedwith 4%paraformalde-
hyde, and incubated with the anti-CagA antibody (AUSTRAL Biologicals).
Alexa Fluor 568-conjugated goat anti-mouse IgG (Invitrogen) was used as
the secondary antibody. To detect the LysoTracker signals, after H. pylori
infection for 5 hr, the AGS cells were incubated with RPMI1640 culturemedium
containing 400 mg/ml kanamycin for 24 hr, and then with LysoTracker Red
DND-99 (Invitrogen) for 90min, followedbyfixationwith 4%paraformaldehyde.
The samples were examined using an FV10i fluorescence microscope
(Olympus).
Measurement of ROS
After H. pylori infection for 5 hr, AGS cells were incubated in RPMI1640 culture
medium containing 400 mg/ml kanamycin for 15 or 24 hr. The cells were incu-
bated with 10 mM CM-H2DCFDA (Invitrogen) in Hanks balanced salt solution
(HBSS) for 60 min at 37C and washed three times with PBS. To label mito-
chondria, the cells were incubated with 10 mMMitoTracker Red FM (Invitrogen)
in HBSS for 30 min. The samples were examined using an FV10i fluorescence
microscope (Olympus). To quantify the intensity of DCF fluorescence, the cells
were dissociated using 1 mM EDTA and subjected to flow cytometry using
a Gallios Flow Cytometer (Beckman Coulter, Brea, CA) and analysis software
(Summit V6.0.2.11185) (Beckman Coulter).
GSH Assay
Intracellular GSH levels were determined using a GSH-Glo Glutathione
Assay Kit (Promega, Madison, WI). The cells (2 3 103 per well) were plated
in 96-well plates. This assay is based on the conversion of a luciferin derivative
to luciferin by glutathione S-transferase in the presence of GSH. The signal
generated in a coupled reaction with firefly luciferase is proportional to the
amount of GSH in the sample. The assay results were normalized using the
GSH standard solution provided with the kit.(B) MKN28 cells were transfected with the pRC/CMV-CD44s or pRC/CMV-CD4
incubated in a medium containing antibiotic for the indicated times, and intrac
independent assays; *p < 0.05, **p < 0.01. Akt and MDM2 phosphorylation, p53 ex
of three independent assays; *p < 0.05, **p < 0.01, compared to each cell at 0 h
(C) Representative staining for LysoTracker Red DND-99 is shown. MKN28 cells
plasmid; cells infectedwithH. pylori (s1m1VacA) for 5 hr were incubated in amediu
LysoTracker Red DND-99. Scale bar = 50 mm.
(D) MKN28 cells were transfected with the pRC/CMV-CD44v expression plasmid;
a medium containing antibiotic with sulfasalazine for 24 hr; and intracellular Ca
represent the mean ± SD of three independent assays; *p < 0.05, **p < 0.01.
(E) Immunostaining of CagA and CD44v9 in human gastric adenocarcinoma. C
tissue specimen from the four different patients. Red staining indicates intracell
Scale bar = 20 mm.
(F) Immunostaining of LC3 and CD44v9 in human gastric adenocarcinoma. The
a CD44v9-positive region. Red staining indicates LC3B-positive puncta and gree
See also Figure S5.
Cell Host &Western Blotting
Total protein (10 mg/lane) was separated on a 4%–12% NuPAGE gradient gel
(Invitrogen) and transferred to a PVDF membrane (Invitrogen), which was
probed with each primary antibody, followed by reprobing with an anti-actin
antibody (Sigma) as the loading control. Signal detection of the immunoreac-
tive bands was facilitated by enhanced chemiluminescence using ECL plus
(GE Healthcare, Piscataway, NJ). Signal quantification was performed using
the ImageJ program (National Institutes of Health).
Statistical Analysis
All values are expressed as means ± SD. The statistical significance of
differences between two groupswas evaluated using Student’s t test. Analysis
was performed using JSTAT statistical software (version 8.2). Statistical signif-
icance was accepted at p < 0.05, unless otherwise indicated.
Tissue Specimens
Human gastric adenocarcinoma tissue specimens were obtained from a
62-year-old female (case 1), a 68-year-old male (case 2), a 72-year-old male
(case 3), a 78-year-old male (case 4), an 80-year-old female (H. pylori-negative
patient), and a 72-year-old male (patient at 40 months after H. pylori eradica-
tion) who underwent endoscopic submucosal dissection at Keio University
Hospital after receiving written informed consent before the procedure.
Pathological diagnosis was well-differentiated adenocarcinoma according to
the Japanese Gastric Cancer Association classification of gastric carcinoma
(14th edition). The study protocol was approved by the ethics committees of
Keio University School of Medicine and registered with the UMIN Clinical Trials
Registry (UMIN000001057; http://www.umin.ac.jp/ctr/). The study was per-
formed in accordance with the principles of the Declaration of Helsinki.
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